Results of Observational Study and Integration of Epinastine 0,05% in Treatment Algorythms of Patients with Seasonal Allergic Conjunctivitis

Objective. To assess tolerability and the time of onset of clinical effect of dual­-action antihistamine agents — Epinepta® (epinastine 0.05 %) and olopatadine 0.1 % in patients with seasonal allergic conjunctivitis (SAC).Subjects and methods. This was a prospective multicenter observational study....

Full description

Bibliographic Details
Published in:Oftalʹmologiâ
Main Authors: D. Yu. Maychuk, E. A. Drozdova, A. A. Tarkhanova, E. E. Zinych
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2024-06-01
Subjects:
seasonal allergic conjunctivitis
epinastine
epinepta®
antihistamine dual­action agents
Online Access:https://www.ophthalmojournal.com/opht/article/view/2377

Similar Items

Similar Items